395 related articles for article (PubMed ID: 27349517)
21. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
Xie Y; Lv H; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2011 Dec; 26(6):681-95. PubMed ID: 21988227
[TBL] [Abstract][Full Text] [Related]
22. A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
Ranki T; Kanerva A; Ristimäki A; Hakkarainen T; Särkioja M; Kangasniemi L; Raki M; Laakkonen P; Goodison S; Hemminki A
Gene Ther; 2007 Jan; 14(1):58-67. PubMed ID: 16900223
[TBL] [Abstract][Full Text] [Related]
23. A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues.
Yamamoto Y; Hiraoka N; Goto N; Rin Y; Miura K; Narumi K; Uchida H; Tagawa M; Aoki K
J Control Release; 2014 Oct; 192():284-93. PubMed ID: 25108153
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
25. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.
Zhu Y; Lv H; Xie Y; Sheng W; Xiang J; Yang J
Cancer Gene Ther; 2011 Sep; 18(9):627-36. PubMed ID: 21660060
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis.
Xie YF; Sheng W; Xiang J; Zhang H; Ye Z; Yang J
Cancer Biother Radiopharm; 2009 Apr; 24(2):261-9. PubMed ID: 19409049
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma.
Galal El-Shemi A; Mohammed Ashshi A; Oh E; Jung BK; Basalamah M; Alsaegh A; Yun CO
Gene Ther; 2018 Jan; 25(1):54-65. PubMed ID: 28925992
[TBL] [Abstract][Full Text] [Related]
29. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.
Wang G; Li G; Liu H; Yang C; Yang X; Jin J; Liu X; Qian Q; Qian W
J Gene Med; 2009 Jun; 11(6):477-85. PubMed ID: 19340843
[TBL] [Abstract][Full Text] [Related]
30. Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo.
Zhu W; Wei L; Zhang H; Chen J; Qin X
J Exp Clin Cancer Res; 2012 May; 31(1):51. PubMed ID: 22640485
[TBL] [Abstract][Full Text] [Related]
31. Armed replicating adenoviruses for cancer virotherapy.
Cody JJ; Douglas JT
Cancer Gene Ther; 2009 Jun; 16(6):473-88. PubMed ID: 19197323
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors.
Kim DR; Park MY; Lim HJ; Park JS; Cho YJ; Lee SW; Yoon HI; Lee JH; Kim YS; Lee CT
Int J Mol Med; 2012 Feb; 29(2):218-24. PubMed ID: 22075951
[TBL] [Abstract][Full Text] [Related]
33. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
[TBL] [Abstract][Full Text] [Related]
34. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.
Zhang H; Zhou X; Xu C; Yang J; Xiang J; Tao M; Xie Y
Cancer Gene Ther; 2016 Jan; 23(1):13-23. PubMed ID: 26564429
[TBL] [Abstract][Full Text] [Related]
35. A novel CRAd in combination with cisplatin enhanced the antitumor efficacy in ovarian cancer.
Zhang B; Liu Y; Zhang P; Wei Y; Yin X; Zheng J
Int J Gynecol Cancer; 2011 Dec; 21(9):1540-6. PubMed ID: 22080895
[TBL] [Abstract][Full Text] [Related]
36. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
37. A novel conditionally replicating "armed" adenovirus selectively targeting gastrointestinal tumors with aberrant wnt signaling.
Liu X; Qian Q; Xu P; Wolf F; Zhang J; Zhang D; Li C; Huang Q
Hum Gene Ther; 2011 Apr; 22(4):427-37. PubMed ID: 20925459
[TBL] [Abstract][Full Text] [Related]
38. [Effect of adenovirus-mediated ING4 and IL-24 co-expression on chemosensitivity to human lung adenocarcinoma in vitro and in vivo].
Zhu Y; Du X; Chen H; Xie Y; Sheng W; Yang J
Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):85-94. PubMed ID: 21553494
[TBL] [Abstract][Full Text] [Related]
39. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
Oosterhoff D; Pinedo HM; Witlox MA; Carette JE; Gerritsen WR; van Beusechem VW
Gene Ther; 2005 Jun; 12(12):1011-8. PubMed ID: 15729367
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging.
Borovjagin AV; McNally LR; Wang M; Curiel DT; MacDougall MJ; Zinn KR
Mol Imaging; 2010 Apr; 9(2):59-75. PubMed ID: 20236604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]